Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0f3a218a73266e3df2aacace1fefbbda |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
filingDate |
2015-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f6f8e50d21fe738696c09e37cd2e0cd |
publicationDate |
2021-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2875742-T3 |
titleOfInvention |
Methods to increase tonic inhibition and treatment of Angelman syndrome |
abstract |
A pharmaceutical composition comprising an effective amount of 4,5,6,7-tetrahydroisoxazolo (5,4-c) pyridin-3-ol (THIP) or a pharmaceutically effective salt thereof and a pharmaceutically acceptable carrier or excipient for its use in a method for treating a human subject with Angelman syndrome, wherein the effective amount is 10 mg to 20 mg. |
priorityDate |
2014-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |